On Awe, Healthy Eating, Mental Health, Ethical Neurotech, and more

_____ Time to wrap-up anoth­er very active month with our Sharp­Brains e‑newsletter sum­ma­riz­ing excit­ing devel­op­ments in brain research, health­care and tech­nol­o­gy — plus a cou­ple fun brain teasers to spark curios­i­ty and inno­va­tion :-) New brain research: Brain scans shed light on the brain net­works sup­port­ing Awe For World Men­tal Health Day let’s review how a healthy…

Read More

Novartis dissolves agreement to market Pear Therapeutics’ prescription digital therapeutics for substance/ opioid abuse

_______________ As San­doz returns mar­ket­ing rights for dig­i­tal ther­a­peu­tics to Pear, what does it mean for co-pro­­mote arrange­ments? (MM&M): “San­doz, the gener­ics divi­sion of Novar­tis, is alter­ing com­mer­cial course, return­ing mar­ket­ing duties for two pre­scrip­tion dig­i­tal ther­a­peu­tics (DTx) back to Pear Ther­a­peu­tics. The move, which some had antic­i­pat­ed, comes 18 months after the two signed…

Read More

CVS Health: Cognitive behavioral therapy (CBT) apps may help you more than sleeping pills

__________ Sleep Ther­a­py for the Mass­es May Be Com­ing to You Soon (The New York Times): “CVS Health wants to help mil­lions of Amer­i­can work­ers improve their sleep. So for the first time, the big phar­ma­cy ben­e­fits man­ag­er is offer­ing a pure­ly dig­i­tal ther­a­py as a pos­si­ble employ­ee ben­e­fit. The com­pa­ny is encour­ag­ing employ­ers to cover…

Read More

Lifestyle and neurotechnology over genetics

?” Dear col­league, It’s remark­able how quick­ly things are chang­ing, final­ly, in brain health and men­tal health — see for exam­ple what’s new with Inter­ax­on, Akili, Neu­raMetrix, Apple, Calm, Halo Neu­ro­science, Mind­strong Health, Novar­tis, Pear Ther­a­peu­tics, and life­long neu­ro­ge­n­e­sis, all in the last 6 months! Please enjoy the May edi­tion of Sharp­Brains eNewslet­ter below, and con­sid­er join­ing the…

Read More

Pear Therapeutics raises $50M to develop and market a portfolio of digital therapeutics for mental health

___ Pear Ther­a­peu­tics rakes in $50M to devel­op addi­tion­al dig­i­tal ther­a­peu­tics (Mobi­Health­News): “Boston- and San Fran­­cis­­co-based Pear Ther­a­peu­tics, mak­er of a pre­scrip­tion dig­i­tal ther­a­peu­tic plat­form, announced today the clo­sure of $50 mil­lion in Series B fund­ing. The round was led by Sin­­ga­­pore-based invest­ment com­pa­ny Temasek, with par­tic­i­pa­tion from return­ing investors 5AM Ven­tures, Arbore­tum Ven­tures, and…

Read More